Research.Patient.info

For patients with advanced/metastatic gastric adenocarcinomas in research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingTherapeutic exploratory (Phase II)
IMMUNOGAST: An umbrella phase 2 trial to assess personalized targeted IMMUNOtherapy-based regimens in recurrent advanced/metastatic GASTric adenocarcinoma patients
IMMUNOGAST is a research study looking at new ways to treat stomach cancer that has spread or come back. It aims to find the best immunotherapy treatments for each person, and is for adults aged 18 and over, both men and women.
France